Target intelligence / Profile preview

Zinc finger and AT-hook domain-containing protein (ZFAT) (ZFAT)

Target
ZFAT
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

Zinc finger and AT-hook domain-containing protein (ZFAT) is a multifunctional transcription factor characterized by 18 C2H2-type zinc finger domains and a single AT-hook motif, highly conserved across vertebrates[1][2][3][5][6]. Predominantly located in the nucleus, ZFAT plays key roles in immune cell survival, apoptosis regulation, and gene expression modulation in B and T lymphocytes. It is expressed mainly in peripheral lymphoid organs, such as thymus, spleen, and lymph nodes, and is essential for hematopoietic differentiation and embryonic development. ZFAT has been implicated as a susceptibility gene for autoimmune thyroid disease and multiple sclerosis through its regulatory effects on immune gene networks, especially by binding to promoter regions of key transcription factors governing blood and vascular development. ZFAT’s structural uniqueness includes uncommon bulged-helix zinc-fingers and modular tandem repeats, which enable specific DNA binding and gene regulation. Deficiency in ZFAT leads to impaired hematopoietic development and is embryonically lethal in knockout mouse models, demonstrating its essential physiological functions. No drugs or direct small-molecule inhibitors or modulators of ZFAT have been identified; thus, it is not currently considered a therapeutic target in a traditional sense, but is an important gene of interest for understanding autoimmune disease, hematopoiesis, and immune cell regulation[2][3][5][6].

Other names
ZFATKIAA1485ZFAT1ZNF406Zinc finger gene in AITD susceptibility regionZinc finger protein 406AITD3zinc finger gene in autoimmune thyroid diseasezinc finger protein ZFAT
02

Biological functions

DNA-bindingTranscriptional regulationRegulation of apoptosisCell survival in immune cellsImmune response modulationHematopoiesis and erythropoiesis regulationCentromeric chromatin stability
03

Disease associations

Autoimmune thyroid diseaseMultiple sclerosisHematopoietic disorders (e.g., failure of primitive hematopoiesis in knockout models)Cancer (suggested in context of apoptosis and cell survival)
04

Safety considerations

Potential risks are theoretical and based on physiological role; as ZFAT knockout is embryonically lethal in mice, any direct modulation could pose risks to hematopoiesis, immune function, and development
05

Biomarkers

Single nucleotide polymorphisms (SNPs) in ZFAT have been associated with susceptibility to autoimmune thyroid disease and multiple sclerosis

Beyond the preview

Go deeper on Zinc finger and AT-hook domain-containing protein (ZFAT) (ZFAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and AT-hook domain-containing protein (ZFAT) (ZFAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call